Toniiq Ashwagandha+, 120 Capsules
UPC: 858111007605
Toniiq Ashwagandha+ is a dietary supplement formulated to support stress response, energy, and mood. It provides a 20x concentrated ashwagandha extract standardized to 10% withanolides, the bioactive compounds associated with ashwagandha's traditional uses, along with black pepper extract (piperine) to enhance absorption.
This product stands out for its high concentration, as the manufacturer notes that many ashwagandha supplements contain non-concentrated powder with less than 2.5% withanolides. The formulation is backed by a five-point testing program that includes third-party verification of raw materials and finished products for active ingredient assay, heavy metals, and microbiology. It is manufactured in the USA with globally sourced ingredients and comes in a 120-capsule bottle, with a suggested use of two capsules daily.
At a glance
Supplement Facts
| Ingredient | Amount Per Serving | % Daily Value |
|---|---|---|
| Ashwagandha | 1,300 mg | † |
| Withanolides | 325 mg | † |
| Black Pepper | 10 mg | † |
| Piperine | 9.5 mg | † |
| † Daily Value not established | ||
Other Ingredients
Vegetable capsule (hydroxypropyl methylcellulose), silicon dioxide & vegetable magnesium stearate.
Label Information
Directions, warnings, and other information directly from the product label.
Suggested Use
Take 2 capsules with a meal daily as a dietary supplement or as recommended by your healthcare professional.
Warning
This product is only intended for healthy adults, 18 years of age or older. Do not take this product if you are pregnant or nursing. Consult with a licensed, qualified healthcare professional before using this or any dietary supplement product. Store bottle tightly closed in a cool, dry place. Keep out of reach of children. Tamper resistant. Do not use if imprinted safety seal under cap is broken or missing.
Product Info
- Brand
- Toniiq
- UPC
- 858111007605
- Package Qty
- 120 count
- Dimensions
- 9.05 x 3.1 x 2.9 in
- Shipping Weight
- 0.58 lb
- First Available
- 11/2024





